Literature DB >> 9671178

Identification of deletions and insertions in the p53 gene using multiplex PCR and high-resolution fragment analysis: application to breast and ovarian tumors.

K Angelopoulou1, E P Diamandis.   

Abstract

We have developed a simple and highly efficient method to detect deletions and insertions in the p53 gene. All 11 exons of the p53 gene were amplified along with a control sequence in four multiplex PCR reactions in the presence of fluorescein-labeled primers. The PCR products were resolved on an automated sequencing gel and the DNA fragments were detected by fluorescence. Using this method, we screened 7 DNA specimens from ovarian tumors, 19 from breast tumors, and 26 from normal breast tissues. No abnormality was found in any of the DNA samples extracted from the normal tissues. A 19 base pair deletion in exon 5 of the p53 gene was detected in one ovarian tumor. Insertions were identified in two breast and two ovarian tumors. The insertions were identical in 3 of these tumors and consisted of a 16 bp repeat within intron 3 of the p53 gene. It appears that the insertion within intron 3 may represent a hot spot for duplication of the normal sequence at that site.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9671178      PMCID: PMC6807817     

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  25 in total

Review 1.  p53 function and dysfunction.

Authors:  B Vogelstein; K W Kinzler
Journal:  Cell       Date:  1992-08-21       Impact factor: 41.582

2.  p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

Authors:  G Gaidano; P Ballerini; J Z Gong; G Inghirami; A Neri; E W Newcomb; I T Magrath; D M Knowles; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

3.  Simple sequence repeat polymorphism within the p53 gene.

Authors:  V Lazar; F Hazard; F Bertin; N Janin; D Bellet; B Bressac
Journal:  Oncogene       Date:  1993-06       Impact factor: 9.867

4.  Frequency and structure of p53 rearrangements in human osteosarcoma.

Authors:  C W Miller; A Aslo; C Tsay; D Slamon; K Ishizaki; J Toguchida; T Yamamuro; B Lampkin; H P Koeffler
Journal:  Cancer Res       Date:  1990-12-15       Impact factor: 12.701

Review 5.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

6.  p53 mutations in ovarian cancer: a late event?

Authors:  R Mazars; P Pujol; T Maudelonde; P Jeanteur; C Theillet
Journal:  Oncogene       Date:  1991-09       Impact factor: 9.867

7.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

Authors:  M B Kastan; Q Zhan; W S el-Deiry; F Carrier; T Jacks; W V Walsh; B S Plunkett; B Vogelstein; A J Fornace
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

8.  Wild-type p53 binds to the TATA-binding protein and represses transcription.

Authors:  E Seto; A Usheva; G P Zambetti; J Momand; N Horikoshi; R Weinmann; A J Levine; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3.

Authors:  M M Wales; M A Biel; W el Deiry; B D Nelkin; J P Issa; W K Cavenee; S J Kuerbitz; S B Baylin
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

10.  Quantification of p53 protein in tumor cell lines, breast tissue extracts and serum with time-resolved immunofluorometry.

Authors:  S Hassapoglidou; E P Diamandis; D J Sutherland
Journal:  Oncogene       Date:  1993-06       Impact factor: 9.867

View more
  1 in total

1.  Statistical strategies to improve the efficiency of molecular studies of colorectal cancer prognosis.

Authors:  P Qu; H Chu; J G Ibrahim; J Peacock; X J Shen; J Tepper; R S Sandler; T O Keku
Journal:  Br J Cancer       Date:  2008-11-18       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.